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Cohesin is a chromatin-bound complex that mediates sister
chromatid cohesion and facilitates long-range interactions
through DNA looping. How the transcription and replication
machineries deal with the presence of cohesin on chromatin
remains unclear. The dynamic association of cohesin with chro-
matin depends onWAPL cohesin release factor (WAPL) and on
PDS5 cohesin-associated factor (PDS5), which exists in two ver-
sions in vertebrate cells, PDS5A andPDS5B. Using genetic dele-
tion inmouse embryo fibroblasts and a combination ofCRISPR-
mediated gene editing and RNAi-mediated gene silencing in
human cells, here we analyzed the consequences of PDS5 deple-
tion for DNA replication. We found that either PDS5A or
PDS5B is sufficient for proper cohesin dynamics and that their
simultaneous removal increases cohesin’s residence time on
chromatin and slows down DNA replication. A similar pheno-
type was observed in WAPL-depleted cells. Cohesin down-reg-
ulation restored normal replication fork rates in PDS5-deficient
cells, suggesting that chromatin-bound cohesin hinders the
advance of the replisome. We further show that PDS5 proteins
are required to recruit WRN helicase-interacting protein 1
(WRNIP1), RAD51 recombinase (RAD51), and BRCA2 DNA
repair associated (BRCA2) to stalled forks and that in their
absence, nascent DNA strands at unprotected forks are de-
graded byMRE11 homolog double-strand break repair nuclease
(MRE11). These findings indicate that PDS5 proteins partici-
pate in replication fork protection and also provide insights into
how cohesin and its regulators contribute to the response to
replication stress, a common feature of cancer cells.
Cohesin is a ring-shaped complex that consists of SMC1,
SMC3, RAD21, and SA/STAG, which can be SA1 or SA2 in
somatic vertebrate cells. This ring maintains cohesion by
entrapping the sister chromatids after DNA replication, which
is essential for faithful chromosome segregation (1). In addi-
tion, cohesin plays an important role in genome organization,
together with the architectural protein CTCF and other tran-
scriptional regulators, that impacts gene expression and influ-
ences cellular processes such as DNA replication and DNA
damage repair (2–6)
Cohesin associates with chromatin by telophase (7), and this
association is dynamic (8). Loading of the complex is facilitated
by a heterodimer ofNIPBL andMAU2, whereas its dissociation
from chromatin ismediated by the releasing factorsWAPL and
PDS5 (9–12) and requires opening of the SMC3-RAD21 inter-
face (13–15). At the time of DNA replication, the replisome
encounters cohesin on chromatin and it is not yet understood
whether this cohesin is pushed, traversed, or dissociated and
transferred behind the fork to embrace the emerging sister
chromatids and establish cohesion (16–21). What is known is
that a fraction of cohesin becomes stably bound to chromatin
after DNA replication, which requires SMC3 acetylation and
recruitment of Cell division cycle associated 5 (CDCA5), com-
monly known as Sororin (22–24). Binding of Sororin to PDS5
displacesWAPL, inactivating cohesin release (25). Thus, PDS5
has opposite functions depending on its binding partner: It pro-
motes cohesin dissociation together with WAPL and stabilizes
cohesive cohesin together with Sororin. There are two PDS5
proteins in vertebrate cells, PDS5A and PDS5B, whose specific
functions remain ill defined (26). Knockoutmice for either gene
die before birth, suggesting that full compensation cannot be
achieved (27). Defects in centromere cohesion are more prom-
inent in PDS5B-deficient cells, suggesting a specific contribu-
tion of PDS5B to cohesion establishment and/or maintenance
in this region (26, 27).
Cohesin promotes repair by homologous recombination
(HR)5 in S and G2 phases by ensuring the proximity of sister
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chromatids (28, 29). In yeast, when replication fork progression
is impeded by addition of hydroxyurea (HU), cohesin accumu-
lates at replication sites and contributes to fork restart after
removal of the drug (30). Moreover, under this condition,
WAPL-dependent cohesin mobilization from ahead to behind
stalled forks has been proposed as a mechanism that protects
fork integrity (31). Whether similar mechanisms operate in
mammalian cells is unknown. PDS5B has been shown to inter-
act with BRCA2 and RAD51 during DNA replication and to be
required for efficient HR-mediated DNA repair in human cells
(32). In vitro assays further suggest that PDS5B can stimulate
RAD51-mediated DNA strand invasion together with BRCA2
(33). PDS5A has not been tested in these studies.
Besides their contribution to genome maintenance through
HR, several recent studies have shown that BRCA2 and RAD51
participate in replication fork protection (34). A fork remodel-
ing mechanism known as fork reversal has been described both
in prokaryotes and in eukaryotes that preserves stalled replica-
tion fork integrity (35). According to current models, stalled
forks are reversed by RAD51 and DNA translocases such as
SMARCAL1 (36, 37). Reversed forks become vulnerable to deg-
radation by nucleases such as MRE11, a step antagonized by a
fork protection mechanism mediated by BRCA2-dependent
RAD51 filament stabilization (38–44). Additional proteins like
WRNIP1 cooperate with RAD51 to safeguard fork integrity
(45).
Here we have explored the contribution of PDS5A and
PDS5B to cohesin dynamics in connection with DNA replica-
tion. We have found that the absence of both PDS5 proteins
leads to increased stability of cohesin on chromatin and results
in replication stress. Singlemolecule analysis indicates that fork
progression rates are reduced in PDS5-deficient cells, a pheno-
type that can be rescued by co-depletion of cohesin or inhibi-
tion of theMRE11 nuclease. Our results also indicate that PDS5
promotes recruitment of BRCA2, RAD51, andWRNIP1 to pre-
serve stalled fork integrity.
Results
Dynamic association of cohesin with DNA is altered in the
absence of PDS5 proteins
To address the relevance of PDS5 proteins for cohesin
dynamics, we carried out inverse fluorescence recovery after
photobleaching (iFRAP) analyses in mouse embryo fibroblasts
(MEFs) derived from Pds5A KO (AKO), Pds5B KO (BKO), and
Pds5A/B double KO (dKO) embryos expressing the cohesin
core subunit RAD21 taggedwithGFP. ACRISPR/Cas9 strategy
was used to add a GFP tag to the C terminus of the Rad21 gene
to ensure physiological expression of the tagged subunit in
these three cell lines (Fig. 1A). Single KO cell lines are homozy-
gous for the Pds5A or Pds5B KO alleles (27). The Pds5 dKO cell
line carries conditional KO alleles of Pds5A and Pds5B in
homozygosis and a Cre-ERT2 transgene that produces a Cre
recombinase that is translocated to the nucleus by addition of
4-hydroxytamoxifen (4-OHT). In the absence of treatment, this
cell line behaves as WT. The GFP-tagged RAD21 protein was
incorporated in cohesin complexes that were loaded on chro-
matin efficiently, as judged by chromatin fractionation and
immunoprecipitation (Fig. S1,A andB ). In iFRAP experiments,
the GFP fluorescent signal was bleached with a laser in half of
the cell nucleus and recovery of fluorescence was monitored by
measuring the difference between the bleached and unbleached
areas over time (Fig. 1B). We performed the experiments in
quiescent cells to avoid the stable population of cohesin present
in S/G2 cells after cohesion establishment and instead focused
on the dynamic binding of cohesin to unreplicated DNA in
G0/G1 cells (8, 23). To that end, confluent MEFs were cultured
for 3 days in low serum before iFRAP was performed. Recovery
of fluorescence after laser treatment was only mildly delayed in
the PDS5A or PDS5B deficient cells (Fig. 1C). To test the effect
of depleting both PDS5 proteins simultaneously, confluentWT
MEFs were cultured in low serum in the presence of 4-OHT for
5 days, or left untreated as control (Fig. S1C). In Pds5 dKO
MEFs, recovery of fluorescence in the bleached region took
significantly longer than in WT MEFs (Fig. 1D). The curve of
fluorescence decay could be fitted using a double-exponential
nonlinear regression and showed that cohesin complexes in
PDS5-deficient cells had a chromatin residence time of 127.5
min, four times greater than the 29.6min calculated for the slow
exchange population in WT cells. These findings indicate that
cohesinmobility is decreased upon elimination of the twoPDS5
proteins in G0-arrested MEFs, as previously shown in HeLa
cells (11, 12), whereas elimination of a single PDS5 protein
barely alters cohesin dynamics.
PDS5 proteins and cell cycle progression
To address the impact of altered cohesin dynamics on cell
cycle progression, we eliminated the two PDS5 proteins in qui-
escent cells and followed their re-entry into the cycle after addi-
tion of serum (Fig. 2A). Entry into S phase, measured by BrdU
incorporation, was impaired in Pds5 dKO MEFs (Fig. 2B). Ini-
tiation of DNA replication relies on licensing of pre-replication
complexes (pre-RCs) that consist of the origin recognition
complex, CDC6, CDT1, and minichromosome maintenance
(MCM) proteins. Transcriptional reactivation of genes encod-
ing some of these initiator proteins, as well as CYCLIN A2, is
delayed in the absence of PDS5 proteins (Fig. 2C). This was not
because of a global reduction of transcription rates, as other
genes including cohesin Smc3 or its loader Nipbl are tran-
scribed at similar rates in both conditions. The delay in the
synthesis of initiator proteins in Pds5 dKOcells is likely respon-
sible for the observed delay in assembly of pre-RCcomplexes on
chromatin (Fig. 2D) and may explain delayed S phase entry
upon serum stimulation (Fig. 2B).
We next generated HeLa cells deficient for PDS5A or PDS5B
by CRISPR/Cas9 (Fig. S2, A and B). We were unable to obtain
clones simultaneously deficient for both proteins, a likely indi-
cation of the relevance of PDS5 proteins for cell viability.
Instead, we either transfected siRNA or expressed an shRNA
against PDS5B in PDS5A KO cells to obtain cells with drasti-
cally reduced levels of both PDS5 proteins (Fig. S2, C and D ).
HeLa cells lacking PDS5A or PDS5B grew more slowly than
control (WT) cells whereas doubly depleted cells grew very
poorly (Fig. S3A). To monitor pre-RC assembly in the absence
of PDS5 proteins in HeLa cells, these were synchronized in
mitosis with nocodazole, and chromatin fractions were ana-
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lyzed at different times after release into fresh media. As in
MEFs, a reduction in MCM3 abundance on chromatin was
observed in PDS5-deficientHeLa cells (Fig. S3B). However, this
was most likely a consequence of the delay in recovering from
the nocodazole arrest (Fig. S3C). When assembly of pre-RCs
was assessed in G1 cells selected by sorting from an asynchro-
nous population, the amount ofMCM3 on chromatin was sim-
ilar in cells with or without PDS5 proteins (Fig. 2E). Taken
together, the results in MEFs and HeLa cells suggest that pre-
venting proper cohesin release does not interfere with pre-RC
complex assembly in early G1 but delays the synthesis of initia-
tor proteins during exit from quiescence or frommitotic arrest.
To avoid this effect, in the experiments presented below we
have used asynchronous populations to address the role of
PDS5 proteins on DNA replication.
Intriguingly, analysis of cell cycle profiles revealed accumu-
lation of HeLa cells in G2/M in the absence of both PDS5 pro-
teins and also an increased fraction of cells with an intermediate
DNA content between 1C and 2C that did not incorporate
BrdU during the time of the pulse (Fig. 3A). Although the
mitotic index of PDS5-deficient cell cultures was similar to that
of control HeLa cells (data not shown), around 20% of cells in S
and G2 phases lacking both PDS5 proteins displayed signs of
replication stress, as evidenced by H2AX staining (Fig. 3B).
Moreover, these cells also show increased sensitivity to anATM
andRad3-related (ATR) kinase inhibitor (Fig. 3C), which is par-
ticularly toxic in cells suffering from endogenous replication
stress (46).
Altered cohesin dynamics impair replication fork progression
We next addressed the cause of replication stress in PDS5-
deficient cells. DuringDNAreplication, the replisome traverses
cohesin-bound genomic regions through a yet-to-be-deter-
mined mechanism. To test whether defective cohesin unload-
ing in the absence of PDS5 proteins hinders replication fork
progression, we employed singlemolecule analyses of stretched
DNA fibers. After consecutive pulses of labeled nucleotides
CldU and IdU (Fig. 4A, red and green tracks, respectively, ), the
length of the green tracks was measured to assess nucleotide
incorporation in ongoing forks. Pds5 dKO MEFs displayed
reduced fork velocity compared with their WT counterparts
(Fig. 4B). In the case of Pds5A KOMEFs, a mild (9%) reduction
Figure 1. Stabilization of cohesin on chromatin in the absence of PDS5 proteins. A, immunoblot analysis of total extracts from MEFs of the indicated
genotypes used in FRAP experiments. One membrane (lanes 1–4) was probed first with anti-RAD21 (upperband, RAD21-GFP; lowerband, untagged RAD21) and
next with GFP. The second membrane (lanes 5–8) was probed first with anti-PDS5B (lanes 5–8) and then with anti-PDS5A. Asterisk indicates remaining PDS5B
signal from the first blot. AKO, Pds5A KO; BKO, Pds5B KO; dKO, Pds5 A/B (double) KO. B, images of a representative FRAP experiment comparing cohesin
dynamics in WT and Pds5 dKO MEFs. Bar, 5 m. See also Fig. S1, A and B. C, graph plotting the difference in fluorescence intensity between bleached and
unbleached regions against time (mean values and S.D.). The curve was fitted using single exponential function. WT, n 13 cells; Pds5A KO, n 13; Pds5B KO,
n 17. Cells grown in rich medium until they reached confluence were kept in low serum for 3 days before imaging. D, as in C, except that the curve was fitted
using a bi-exponential function. WT, n 13 cells; dKO, n 12 cells. In this case, cells were kept for 5 days in low serum without (WT) or with (dKO) 4-OHT. See
also Fig. S1C.
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in median fork rate was observed (Fig. 4C). Despite being statisti-
cally significant, the biological relevance of small variations in fork
speed should be interpreted with caution as some studies have
estimated an experimental variability of around 10–15% for fork
speed in fiber assays (47). No major differences were observed
between Pds5B KO MEFs and their WT littermates (Fig. 4D).
WAPL works together with PDS5 to dissociate cohesin (10).
When Wapl is down-regulated inMEFs by siRNA, forks progress
alsomore slowly (Fig. 4E). Overall, these results highlight the cor-
relation between cohesin dynamics assayed by FRAP experiments
and DNA replication progression assayed by fiber assays.
To corroborate our results in a different cell line, we used
HeLa cells deficient for PDS5A, PDS5B, or both, and confirmed
that the lack of a single PDS5protein does not perturb fork rates
whereas elimination of almost all PDS5 does (Fig. 4F). Down-
regulation of WAPL in HeLa cells produces similar results (Fig.
4G).We reasoned that if slower fork progression in the absence
of PDS5 orWAPLwas due to the presence of chromatin-bound
cohesin complexes hindering fork passage, the observed defects
should be rescued by removing or reducing the number of such
obstacles. Indeed, down-regulation of cohesin by treatment
with an siRNA against SMC1 restored fork progression in
PDS5-deficient HeLa cells (Fig. 4F, last column).
PDS5 proteins are required for BRCA2-mediated protection of
stalled forks
When fork progression is halted, transient fork reversal fol-
lowed by recruitment of fork protection proteins including
Figure 2. PDS5-deficient cells show delayed re-entry into cell cycle after arrest. A, scheme of the experiment and immunoblot analyses of cell extracts at
the time of release into rich medium. To estimate the extent of depletion, decreasing amounts of WT cell extracts were loaded for comparison. Tubulin, loading
control. B, BrdU incorporation profiles in WT and dKO MEFs at different time points after release from G0 arrest analyzed by flow cytometry. The percentage of
cells that incorporated the nucleotide analogue during a 30-min pulse is indicated. C, quantitative PCR analyses of the mRNA levels of indicated genes. Bars
represent the -fold change in dKO over WT cells at three time points after release. Results from two experiments are shown. D, immunoblot of total cell extract
and chromatin fractions of WT and dKO MEFs at the indicated time points after serum stimulation. E, immunoblot analyses of total cell extract and chromatin
fractions of G1 HeLa cells obtained by FACS. WT, unedited HeLa cells; AKO shB, cells edited to knock out PDS5A and expressing an shRNA against PDS5Bupon
treatment with doxycycline (5 days). The cytoplasmic kinase MEK2 and histone H3 are used as controls for the fractionation procedure.
Cohesin dynamics and DNA replication
J. Biol. Chem. (2020) 295(1) 146–157 149
BRCA2, RAD51, and WRNIP1 provides a mechanism to pre-
serve fork integrity until the problem is solved and replication
can be resumed. Previous results suggest that, at least in the
context of irradiation, PDS5B promotes BRCA2 recruitment to
DNA damaged foci (32).We therefore asked whether the PDS5
proteins could also participate in BRCA2 recruitment upon
fork stalling to preserve fork integrity. Because normal cells
display few BRCA2 foci unless subject to replication stress, we
treated PDS5-proficient and -deficient HeLa cells with HU and
analyzed them by immunofluorescence. Reduced numbers of
BRCA2 foci were detected in cells with low levels of PDS5A and
PDS5B (Fig. 5A). Assessment of RAD51 foci formation under
the same conditions showed also a clear decrease in PDS5-de-
ficient cells (Fig. 5B). In the case of WRNIP1, no suitable re-
agents for immunofluorescence were available and we evalu-
ated its accumulation on chromatin upon HU treatment by
immunoblot analysis of chromatin fractions.WRNIP1 associa-
tion with chromatin was strongly impaired in the absence of
both PDS5 proteins and, to a lesser extent, in cells carrying only
PDS5A or PDS5B (Fig. 5C). In this biochemical fractionation
assay, the accumulation of RAD51 on chromatin was also
impaired, in agreement with the immunofluorescence results.
Finally, a physical interaction between WRNIP1, RAD51, and
PDS5 proteins was detected by immunoprecipitationwith anti-
bodies against PDS5A and PDS5B from extracts of cells treated
with HU (Fig. 5D). An antibody against the cohesin subunit
SMC1 also pulled down WRNIP1 and RAD51, suggesting that
these proteins interact with cohesin bound to PDS5.Moreover,
BRCA2 and RAD51 foci formation under replication stress
conditions was also compromised in HeLa cells treated with an
siRNA against cohesin SMC1 (Fig. S4). Taken together, these
results indicate that the two PDS5 proteins participate in the
Figure 3. PDS5 deficient cells show replication stress. A, BrdU incorporation profiles in WT and AKOshB HeLa cells (top) and histograms showing
percentage of cells in each phase of the cell cycle for two different experiments (bottom). Cells in S phase that do not incorporate BrdU in the time of the
pulse are highlighted. B, representative images of HeLa cells with (WT) or without PDS5 proteins (AKOshB) stained with antibodies against H2AX and
geminin, a protein absent in G1. Cells showing clear H2AX staining are indicated (red line). Scale bar, 50 m. The fraction of H2AX-positive cells in S/G2
phase (labeled with geminin) was quantified among n  2000 cells in each condition and plotted below. Bars represent mean and S.D. from three
different experiments. A t test was used to calculate statistical significance (**, p  0.05). C, HeLa cells with (WT) or without PDS5 proteins (AKOshB)
were cultured in the presence of the indicated concentrations of the ATR inhibitor AZ-20 for 48 h and viability was calculated comparing with cell
numbers in untreated condition. Mean and S.E. from three experiments are shown; p values were calculated with two-way ANOVA and Bonferroni’s
post-test; **, p  0.0035; ***, p  0.0004).
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recruitment and/or stabilization of the fork protection complex
at stalled forks and further suggest that they do so in the context
of cohesin.
PDS5 proteins protect nascent DNA strands from MRE11
degradation
In the absence of proper fork protection, the MRE11
nuclease degrades nascent DNAs at stalled forks. Because
PDS5-deficient cells fail to accumulate BRCA2, RAD51, and
WRNIP1 after HU treatment, we asked whether even in the
absence of HU, stalled forks generated by chromatin-bound
cohesin were susceptible to MRE11 degradation in these cells.
Consistent with this possibility, DNA fiber assays revealed a
significant increase in green track length in PDS5-deficient
HeLa cells that were treated with mirin, a chemical inhibitor of
MRE11, when compared with untreated cells (Fig. 6A). As
expected, mirin had no effect onWT cells. Similar results were
observed in Pds5 dKO MEFs, although in this case the rescue
was partial (Fig. 6B), and in HeLa cells depleted of WAPL (Fig.
6A, right). Moreover, down-regulation of the SMARCAL1
translocase involved in fork reversal restored track length in
PDS5-deficient HeLa cells (Fig. 6C), further supporting the
hypothesis that stalled forks generated by impaired cohesin
dynamics are processed by fork reversal. Cells with reduced
levels of cohesin exposed to HU to generate fork stalling also
displayed shorter green track length that was rescued by addi-
tion of mirin (Fig. 6D). Depletion of both PDS5 proteins in cells
treated with HU also resulted in an increased fraction of forks
unable to resume DNA synthesis after removal of the drug,
whereas depletion of a single PDS5 protein did not have conse-
quences for fork restart (Fig. S5). Finally, we also observed that
accumulation of H2AX in PDS5-deficient cells could be par-
Figure4. Slow forkprogression in cells lackingbothPDS5proteinsorWAPL.A, schematic representation of DNA fiber labeling with CldU and IdU (top) and
examples of DNA fibers selected from micrographs of WT and Pds5 dKO MEFs (bottom). Scale bar, 10 m. B–D, dot plots showing the distribution of fork rate
values in MEFs of the indicated genotypes. In B, WT and Pds5 dKO pairs are the same clone treated or not with 4-OHT. C andD, WT and KO pairs are clones from
littermate embryos. Results from three different clones are merged as they were not significantly different (n 300 measurements per clone). Horizontal lines
indicate median values (value above). p values were calculated with Mann-Whitney test; ****, p  0.0001. C, asterisk appears in red because despite being
statistically significant, the small difference between WT and Pds5AKO is unlikely to be biologically relevant. E, same as inB–D, but for two experiments in which
WT MEFs were transfected with siRNA against Wapl (siWapl) or mock transfected as control (n 300 measurements per experiment per condition). The stress
caused by transfection is the likely reason for the reduced fork progression rates of mock-transfected WT MEFs in these experiments compared with untrans-
fected WT MEFs in B–D. Immunoblot detection of WAPL for one of the experiments is shown on the right. F, distribution of fork rate values for HeLa cells
unedited (WT) or knockout forPDS5A (AKO) that were transfected with the indicated siRNAs.n900 measurements/condition pooled from three experiments.
p values were calculated with Kruskal-Wallis test followed by Dunn’s post-test; ****, p 0.0001; ns, not significant). Immunoblot analysis for one of the three
experiments is shown on the right. G, distribution of fork rate values in HeLa cells (WT) mock transfected or transfected with siRNA against WAPL after 72 h. A
blot showing remaining levels of WAPL is shown on top. Data from three independent experiments are pooled (n 900 measurements/condition; p values
were calculated with Mann-Whitney test; ****, p 0.0001).
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tially alleviated by mirin (Fig. 6E). Together, these results sug-
gest that PDS5 proteins are required to ensure proper fork pro-
tection.Moreover, cohesinmobilizationmediated by PDS5 and
WAPL is an essential step in this process.
Discussion
Replication fork protection has emerged as a keymechanism
to guard cells against genome instability (34, 48, 49). Under
replication stress conditions, nascent DNA strands at stalled
forks can be degraded by nucleases such asMRE11 unless prop-
erly protected. Many proteins participate in this protection
including BRCA2, RAD51,WRNIP1, or Fanconi anemia pro-
teins (37, 40, 43–45). We have now added cohesin and its
regulator PDS5 to this list. Previous studies had established
sister chromatid cohesion mediated by cohesin as an impor-
tant process to ensure HR-mediated DNA repair (28, 29, 50,
51). The results presented here argue that, in addition, cohe-
sin participates in fork protection most likely through its
regulator PDS5.
Our results are consistent with those recently published by
Carvajal-Maldonado et al. (52), who first showed that depletion
of PDS5 proteins results in replication fork progression defects
that are rescued by MRE11 inhibition. However, they differ in
two important aspects. First, contrary to the conclusion that the
role of PDS5 proteins in replication fork progression is uncou-
pled from BRCA2, we find that they are closely related. Second,
single depletion of PDS5A or PDS5B did not result in defective
fork progression or stabilization in our study, suggesting that
the two variants play a redundant role in this process. In con-
trast, Carvajal-Maldonado et al. found similar defects after
depleting only PDS5A, PDS5B, or WAPL. Regarding the con-
nection between PDS5 and BRCA2, Carvajal-Maldonado et al.
(52) argue that PDS5 binding to chromatin is independent of
BRCA2, the latter being only required in replication stress con-
ditions. Although this is true, it is important to note that the
presence of unreleased cohesin in PDS5-deficient cells gener-
ates stalled forks but depletion of BRCA2 does not. Thus,
BRCA2 depletion, but not PDS5 depletion, requires addition of
HU to uncover a fork protection problem. The same reasoning
can be used for cohesin. Reduction of cohesin levels does not
cause significant problems to replication fork progression (3).
However, upon replication stress caused by HU, we show here
that stalled forks are not properly protected in the absence of
cohesin and are degraded by MRE11 nuclease.
Regarding the apparent discrepancies in single versus double
depletion of PDS5 proteins, our results are consistent with the
observation that absence of a single PDS5 protein does not alter
cohesin unloading, as measured by FRAP both in MEFs (this
study) and HeLa cells (11), and by measuring the amount of
cohesin present on chromatin by immunofluorescence in the
two cell types (12, 27).Moreover,we show that bothPDS5Aand
PDS5B interact with fork protection pathway components. It is
conceivable that the ratio of cohesin to PDS5A/B is slightly
different in HeLa cells (used in our study) and U2OS cells used
by Carvajal-Maldonado et al. (52). Alternatively, additional fac-
tors may account for the differences in our results. Neverthe-
less, both studies support the model that stably chromatin-
bound cohesin hinders the advance of the replication fork and
Figure5.PDS5proteinsare required for recruitmentor stabilizationofBRCA2,RAD51,andWRNIP1onchromatinafterHUtreatment.A,quantification
of HU-induced BRCA2 foci in HeLa cells with (WT) or without PDS5 proteins (AKOshB) treated with 10 mM HU for 24 h. Median values are indicated with the
black horizontal line. At least 190 cells were analyzed per condition in each of two independent experiments with similar results (only one is shown). p values
were calculated with Kruskal-Wallis test followed by Dunn’s post-test; ****, p 0.0001; ns, not significant. Representative images for HU-treated cells appear
on the right. Scale bar, 10 m. B, quantification of HU-induced RAD51 foci, as in A. At least 580 cells were analyzed per condition in each of two independent
experiments with similar results (only one is shown). C, immunoblot analyses of total cell extracts and chromatin fractions of HeLa cells with or without one or
both PDS5 proteins, as indicated, and treated with 2.5 mM HU for 24 h to analyze recruitment of RAD51 and WRNIP1. D, immunoblot analyses of immunopre-
cipitates (IP) obtained with antibodies against cohesin SMC1, PDS5A, PDS5B, or IgG as control, from extracts prepared from HeLa cells treated with 2.5 mM HU
for 24 h under mild crosslinking condition. An aliquot of the flow-through (FT) was also included to estimate the efficiency of the pulldown.
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that fork reversal occurs upon fork stalling in the absence of
PDS5 proteins.
The model presented in Fig. 7 proposes that PDS5 and
WAPL are required for transferring cohesin from ahead to
behind the fork and this has two effects. First, it allows proper
progression of the replisome that would otherwise be hindered
by the presence of cohesin. Second, it promotes protection of
stalled forks being upstream of the BRCA2 protection pathway.
The relative importance of these two effectsmay depend on the
cell type, as forHeLa cells we find complete rescue of fiber track
lengths by mirin, whereas in MEFs the rescue is only partial,
suggesting that in the human cells the main effect is on the fork
protection pathway, whereas in mouse cells both effects are in
place. Cohesin transfer may involve a transient opening of the
ring in concert with replisome components, a mechanism pro-
posed to explain cohesion establishment during DNA replica-
tion (19, 20). When this transfer is impaired by depletion of
PDS5 orWAPL, or when cohesin is absent, recruitment of fork
protection proteins is reduced and the stability of the stalled
fork is compromised. A requirement ofWAPL-mediated cohe-
sin mobilization to preserve stalled fork integrity has been
recently reported in budding yeast grown in the presence ofHU
(31). We cannot conclude from our results that PDS5 proteins
are directly responsible for this recruitment. However, mam-
malian 2-hybrid experiments and co-immunoprecipitation
reactions with purified proteins showing a direct interaction
between PDS5 and BRCA2 support this possibility (32, 33).
PDS5 proteins have in fact emerged as critical regulators of
cohesin behavior and function through their ability to interact
with many regulators including WAPL, Sororin (CDCA5),
Figure6. PDS5proteins are required toprotect stalled forks fromMRE11-dependentDNAdegradation.A, scheme of the experimental design. Dot plots
show green track length distribution in HeLa cells unedited (WT) or knockout for PDS5A (AKO), mock transfected or transfected with siPDS5B or siWAPL, and
treated or not with 50 M mirin. Data from three independent experiments are pooled (n  900 measurements/condition; p values were calculated with
Kruskal-Wallis test followed by Dunn’s post-test; ****, p 0.0001; ns, not significant). In dot plots, horizontal lines indicate median values. B, as in A, but using
WT and Pds5dKO MEFs.C, green track length was measured in HeLa cells unedited (WT) or knockout for PDS5A (AKO) and transfected siRNAs against PDS5B and
SMARCAL1, as indicated (left). Protein levels were assessed by immunoblot (right). Data from three independent experiments are pooled (n 900 measure-
ments/condition; p values were calculated with Kruskal-Wallis test followed by Dunn’s post-test; ****, p 0.0001; ns, not significant). D, to test MRE11-depen-
dent DNA degradation in HeLa cells with low levels of cohesin, fork stalling was induced by treatment with 6 mM HU for 4 h after CldU and IdU pulses and green
track length measured (n 900 measurements/condition; p values calculated with Kruskal-Wallis test followed by Dunn’s post-test; ****, p 0.0001; ns, not
significant). E, quantification of cells showing immunofluorescent staining for H2AX (as in Fig. 3B) in WT and AKOshB HeLa cells treated or not with 50 M
mirin. Data from two separate experiments are shown.
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ESCO1 acetyltransferase, and HASPIN (9, 25, 27, 53, 54). Their
interaction with components of the fork protection pathway
adds yet another activity of cohesin to ensure accurate duplica-
tion and segregation of the genome.
Experimental procedures
MEF isolation and culture
Three mouse lines were used in this study: Pds5A / ,
Pds5B/, and Pds5A f/f; Pds5B f/f; Cre-ERT2 (27).Mice were
housed in a pathogen-free animal facility following the animal
care standards of the institution. All procedures have been
revised and approved by the required authorities (Comunidad
Autónoma deMadrid). PrimaryMEFswere isolated fromE12.5
embryos and cultured in DMEM supplemented with 20% FBS
at 37 °C under 90% humidity and 5% CO2. With the exception
of FRAP experiments, performed in MEFs immortalized with
SV40, all other experiments reported here use primary, low
passage MEFs. To ablate Pds5A and Pds5B expression simulta-
neously, double conditional knockout MEFs (Pds5A f/f; Pds5B
f/f; Cre-ERT2) were cultured in medium with 1 M 4-OHT for
at least 5 days and the efficiency of elimination of PDS5A and
PDS5B proteins was assessed by Western blotting. For RNAi,
100 nM siRNA againstWapl (Table S1) was introduced inMEFs
using the Neon Transfection System (Invitrogen) and knock-
down efficiency was assessed after 72 h by Western blotting.
Generation and culture of HeLa cell clones deficient for PDS5
proteins
HeLa cells were grown at 37 °C with 90% humidity and 5%
CO2 in DMEM (Lonza) supplemented with 10% FBS (Sigma-
Aldrich) and 10% penicillin/streptomycin (Invitrogen). HeLa
cell clones deficient for PDS5A or PDS5B were generated with
single-guide RNA (sgRNA) cloned into the BbsI site of dual
Cas9/sgRNA expression vector pX458 (Addgene plasmid 48138)
(55).Cellswere transfectedusingLipofectamine2000 (Invitrogen)
and 48 h later single GFP-positive cells were sorted into 96-well
plates for isolation of single-cell clones. Following clone expan-
sion, PDS5A and PDS5B protein levels were assessed byWestern
blotting to selectone tobeused in subsequentanalyses.The region
of each gene containing the sequence targeted by the sgRNAswas
amplified from genomic DNA from the selected clones, cloned
and sequenced to confirm gene editing. Because we could not
obtain HeLa clones deficient for both PDS5A and PDS5B, double
depletion was achieved by RNAi of PDS5B in PDS5A KO cells.
Stable PDS5A KO-shPDS5B and PDS5B KO-shBHeLa cells were
generated by infection of TRIPZ lentiviral vectors carrying induc-
ible shRNAs (V2THS_200579, V3THS_346828, V3THS_346830,
Dharmacon). After puromycin selection, a polyclonal population
was obtained in which expression of PDS5B shRNA was induced
with 2g/ml doxycycline (Sigma) for 5 days. Alternatively, siRNA
transfections for PDS5B, and also for SMC1 or WAPL or
SMARCAL1 (Table S1), were carried out using DharmaFECT
(Dharmacon) at 50 nM and cells were harvested 72 h post
transfection.
Cell extract preparation and immunoprecipitation
Whole cell extract samples for immunoblot analyses were
prepared from cells lysed in Laemmli Sample Buffer at 10,000
cells/l, sonicated, and boiled for 5 min at 95 °C. Biochemical
fractionation inMEFs andHeLa cells to assess pre-RC assembly
was performed as described (56), but using 0.05% Triton X-100
for cell lysis. For the analysis of WRNIP1 and RAD51 recruit-
ment to chromatin (Fig. 5C), we used the protocol described in
Ref. 57. MEF extract used for immunoprecipitation was pre-
pared lysing cells on ice for 30min in lysis buffer (0.5%Nonidet
P-40 in TBS supplemented with 0.5 mM DTT, 0.1 mM PMSF
and 1 complete protease inhibitor mixture (Roche)) and son-
icated. ThenNaClwas added to 0.3M and the extract rotated for
30 min at 4 °C to extract chromatin-bound proteins. Salt con-
centration was then lowered to 0.1 MNaCl by dilution and glyc-
erol added to 10% final concentration. Extracts were incubated
with the specific antibodies for 2 h at 4 °C and rotated with 1/10
volume of protein A agarose beads for 1 h at 4 °C. For immuno-
precipitation in mild crosslinking conditions (Fig. 5D), HeLa
cells were treated with 1 mM dithiobis(succinimidyl propio-
nate) (DSP) (Thermo Fisher Scientific) for 20min at room tem-
perature, and then DSP was replaced with 25 mM Tris-HCl, pH
7.5, for 10 min at room temperature to quench the reaction.
Cells were scraped in ice-cold PBS, resuspended in lysis buffer
(25 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM EDTA, 5% glyc-
erol, 1%Nonidet P-40) and sonicated. Extracts were clarified by
high-speed centrifugation and incubated with antibodies cou-
pled to Dynabeads M-270 Epoxy (Thermo Fisher) overnight at
4 °C. Beads were washed with lysis buffer and immunoprecipi-
tated proteins were eluted in Laemmli Sample Buffer, boiled for
5 min, and analyzed by SDS-PAGE and immunoblotting. Anti-
bodies are listed in Table S2.
Figure 7.Model for cohesin andPDS5 function at stalled forks. Top, cohe-
sin ahead of the replisome needs to be unloaded by PDS5-WAPL to allow
replication fork passage. Released cohesin is reloaded in the wake of the fork
(20). In the event of fork stalling caused by HU, cohesin-PDS5 reloaded behind
the fork promotes the recruitment of fork protective factors RAD51, BRCA2,
and WRNIP1 to stabilize stalled forks. Middle, in absence of PDS5 or WAPL,
impaired cohesin mobilization would result in fork stalling without addition
of HU. Impaired recruitment of fork protective factors would lead to MRE11
degradation of nascent DNA strand and eventually to fork collapse. Bottom,
the absence of cohesin under replication stress conditions generated by
addition of HU has similar consequences for replication forks.
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Flow cytometry analysis
For BrdU incorporation and DNA content analysis, cells
were pulsed with 10 M BrdU (Sigma) for 30 min before har-
vesting. Cells were trypsinized, washed in PBS, and fixed with
cold (20 °C) 70% ethanol for at least 24 h. DNA denaturation
and permeabilizationwas carried outwith 2NHCl for 20min at
room temperature. Cells were washed twice in PBS, treated
with blocking solution (1% BSA, 0.05% Tween 20 in PBS) for 15
min at room temperature and incubatedwith FITC-conjugated
anti-BrdU antibody (BD Biosciences, Pharmingen) for 1 h at
37 °C. ForDNAcontent analysis, cells were stained overnight at
4 °C with 25 g/ml propidium iodide (Sigma-Aldrich) in pres-
ence of 10 g/ml RNase A (Qiagen). For obtaining cells in G1
phase, cells were stained with 7.5 g/ml Hoechst 33342 (Invit-
rogen) and sorted byDNA content using a BD Influx sorter (BD
Biosciences).
Single-molecule analysis of DNA replication in stretched
fibers
Exponentially growing cells were sequentially pulse-la-
beled for 20 min with 50 M chlorodeoxyuridine (CldU) and
250 M iododeoxyuridine (IdU) to analyze fork progression
as described (58). In some experiments, 50 Mmirin (Sigma-
Aldrich) was added 30 min before CldU. To evaluate fork
restart, cells were incubated in 6 mM HU for 4 h between the
two pulses. In all cases, ImageJ software was used for analy-
sis. To estimate fork rate, at least 300 tracks were measured
per condition. The conversion factor 1 m  2.59 kb was
used (59). At least 500 tracks were measured to estimate
percentage of fork restart.
FRAP in MEFs
One MEF clone of each genotype (WT, Pds5A KO, Pds5B
KO, and Pds5 dKO) was immortalized using SV40 large T anti-
gen and used to generate RAD21-GFP expressing cell lines by
CRISPR-mediated homologous recombination, as described
(53).GFP expressing cellswere selected by sorting.Apolyclonal
population was characterized by immunoblotting and immu-
noprecipitation (Fig. S1) and used for these studies. For Pds5
dKOMEFs, cells at full confluence were starved in DMEM sup-
plemented with 0.1% FBS for 5 days before performing the
experiment. In constitutive Pds5A or Pds5B KO MEFs, cells
were arrested for 3 days. FRAP experiments were performed in
a Leica TCS-SP5 (AOBS) confocal microscope using a 40/1.2
NAHCXPLAPOobjective with immersion oil. Cells were kept
in a climate chamber at 37 °C with 5% CO2 during the experi-
ment. Image acquisition used the HCSA software in LAS AF
2.7. Cells were photobleached with an argon laser, and the
recovery was monitored by live-cell imaging taking pictures
everyminute. Videos were analyzed using Fiji software (60) and
statistical analysis and nonlinear regression with GraphPad
Prism.
Cell staining and imaging
Cells grown on poly-L-lysine–treated coverslips were fixed
for 15 min in 4% paraformaldehyde and permeabilized with
0.5% Triton X-100 in PBS for 5 min at room temperature.
Coverslips were incubated with blocking solution (3% BSA,
0.05% Tween 20 in PBS) for 30 min followed by incubation
with primary (Table S2) and secondary antibodies (1:200 in
blocking solution) and DNA staining with DAPI (Sigma).
ProLong Gold was used as mounting media. For Geminin,
H2AX, RAD51, and BRCA2 staining, images were acquired
with TCS-SP5 (AOBS) confocal microscope (Leica micro-
systems) and analyzed with Definiens Developer XD v2.5
software (Definiens). For foci quantification, a custom rule-
set was employed. In brief, nuclei segmentation was per-
formed using DAPI signal and foci detection was performed
with contrast and size splitting algorithms. The output file
contains information regarding nuclei size, foci number per
nucleus, size, and intensity.
Quantitative RT-PCR
Total RNA was extracted using RNeasy kit (Qiagen) and
treated with DNaseI (Ambion), and cDNAs were prepared
using SuperScript II reverse transcriptase (Invitrogen). qRT-
PCR analysis was performed in triplicates using the SYBR
Green PCRMasterMix and an ABI Prism® 7900HT instrument
(Applied Biosystems®). Quantifications were normalized to
endogenous GAPDH, using the Ct method. Primer sequences
are listed in Table S1.
Viability assays
For treatment with the ATR inhibitor AZ-20 (AstraZeneca),
5000 cells were seeded per well in a 96-well tissue culture plate
and increasing concentrations of AZ-20 added to the media.
Cell viability was assessed after 48 h using a luminescent system
(CellTiter-Glo, Promega), according to themanufacturer’s pro-
tocol. For proliferation assays, 4000 cells (WT, PDS5A KO, or
PDS5B KO) or 8000 cells (PDS5A KOshB, incubated with
doxycycline for 72 h before seeding) were seeded per well in
96-well tissue culture plate at day 0. Proliferation was moni-
tored for the following 4 days using a colorimetric assay (Cell-
Titer 96 AQueous One Solution Cell Proliferation Assay,
Promega).
Statistical analysis
Statistical analyses were performed using Prism v7.0 (Graph-
Pad Software). For comparison of two data groups, two-tailed
unpaired Student’s t test was used if the data assumed a Gauss-
ian distribution.Otherwise, statistical differenceswere assessed
with nonparametricMann-Whitney test. Formultiple compar-
ison analysis, analysis of variance (ANOVA) and Bonferroni’s
post-test were employed if the data assumed a Gaussian distri-
bution.Otherwise, nonparametric Kruskal-Wallis test followed
by Dunn’s post-test was used. In all cases, ns, p  0.05; *, p 
0.05; **, p 0.01; ***, p 0.001; ****, p 0.0001.
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